AR025456A1 - Mesoprogestinas (moduladores de receptor de progesterona) como componentes de composiciones utilizadas para la terapia de sustitucion hormonal (trh) - Google Patents
Mesoprogestinas (moduladores de receptor de progesterona) como componentes de composiciones utilizadas para la terapia de sustitucion hormonal (trh)Info
- Publication number
- AR025456A1 AR025456A1 ARP000104537A ARP000104537A AR025456A1 AR 025456 A1 AR025456 A1 AR 025456A1 AR P000104537 A ARP000104537 A AR P000104537A AR P000104537 A ARP000104537 A AR P000104537A AR 025456 A1 AR025456 A1 AR 025456A1
- Authority
- AR
- Argentina
- Prior art keywords
- hrt
- replacement therapy
- components
- mesoprogestines
- compositions used
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Uso de mesoprogestinas como componentes farmacéuticos para la fabricacion de un medicamento para la terapia de sustitucion hormonal (TRH) y como componentepara el uso combinado junto con un estrogeno para la fabricacion de un medicamento para TRHasí como en métodos de TRH respectivos y en métodos para tratar lainsuficiencia hormonal y síntomas de irregularidad hormonal. Las mesoprogestinas se definen como compuestos que disponen de actividades tanto agonísticas comoantagonísticas en elreceptor de progesterona (RP) in vivo. Estabilizan la funcion del RP en un nivel intermedio entre agonístico y antagonístico. Lasprogestinas y las antiprogestinas no permiten alcanzar estados funcionales correspondientes.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38614099A | 1999-08-31 | 1999-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR025456A1 true AR025456A1 (es) | 2002-11-27 |
Family
ID=23524333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000104537A AR025456A1 (es) | 1999-08-31 | 2000-08-31 | Mesoprogestinas (moduladores de receptor de progesterona) como componentes de composiciones utilizadas para la terapia de sustitucion hormonal (trh) |
Country Status (33)
| Country | Link |
|---|---|
| EP (1) | EP1605924B1 (es) |
| JP (1) | JP2003513908A (es) |
| KR (1) | KR100729311B1 (es) |
| CN (1) | CN1454088A (es) |
| AR (1) | AR025456A1 (es) |
| AT (1) | ATE413168T1 (es) |
| AU (1) | AU781836B2 (es) |
| BG (1) | BG65846B1 (es) |
| BR (1) | BR0013710A (es) |
| CA (1) | CA2383659C (es) |
| CO (1) | CO5200773A1 (es) |
| CZ (1) | CZ301412B6 (es) |
| DE (1) | DE60040764D1 (es) |
| EA (1) | EA007840B1 (es) |
| EE (1) | EE200200102A (es) |
| ES (1) | ES2316402T3 (es) |
| HR (1) | HRP20020266A2 (es) |
| HU (1) | HUP0202460A3 (es) |
| IL (2) | IL148417A0 (es) |
| LT (1) | LT5011B (es) |
| LV (1) | LV12942B (es) |
| MX (1) | MXPA02002190A (es) |
| NO (1) | NO20021000L (es) |
| NZ (1) | NZ517469A (es) |
| PE (1) | PE20010581A1 (es) |
| PL (1) | PL198798B1 (es) |
| RO (1) | RO122180B1 (es) |
| RS (1) | RS50396B (es) |
| SI (1) | SI20851B (es) |
| SK (1) | SK287121B6 (es) |
| UA (1) | UA75339C2 (es) |
| WO (1) | WO2001034126A2 (es) |
| ZA (1) | ZA200201621B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1525215B1 (de) * | 2002-08-02 | 2006-09-06 | Schering Aktiengesellschaft | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie |
| DE10236405A1 (de) | 2002-08-02 | 2004-02-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
| US20040097591A1 (en) * | 2002-11-18 | 2004-05-20 | Kristof Chwalisz | Use of selective progesterone receptor modulators for the treatment of androgen deficiency |
| RU2611370C1 (ru) * | 2016-01-12 | 2017-02-21 | Общество с ограниченной ответственностью Медицинская Корпорация "РАНА" | Применение препарата Лаеннек для уменьшения или устранения проявления менопаузальных симптомов (варианты) |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2054271A (en) | 1932-05-17 | 1936-09-15 | Schering Kahlbaum Ag | Production of crystallized hormone esters |
| DE699310C (de) | 1936-11-20 | 1940-11-27 | Chemische Ind Ges | Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols |
| US2225419A (en) | 1937-03-01 | 1940-12-17 | Schering Corp | Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols |
| US2611773A (en) | 1951-08-21 | 1952-09-23 | Upjohn Co | Estradiol 17-cyclopenetanepropionate |
| US2990414A (en) | 1957-03-26 | 1961-06-27 | Syntex Sa | 17-undecenoate of estradiol |
| US4729999A (en) * | 1984-10-12 | 1988-03-08 | Bcm Technologies | Antiestrogen therapy for symptoms of estrogen deficiency |
| MX9301121A (es) * | 1992-03-02 | 1993-09-01 | Schering Ag | Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina. |
| TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
| DE4225623C2 (de) * | 1992-08-03 | 1994-06-30 | Karl Hehl | Verfahren zur Herstellung einer pulverförmigen Spritzgußmasse für die Herstellung von Porzellan und deren Verwendung |
| US5468736A (en) * | 1993-02-25 | 1995-11-21 | The Medical College Of Hampton Road | Hormone replacement therapy |
| DE4332283A1 (de) * | 1993-09-20 | 1995-04-13 | Jenapharm Gmbh | Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE4332284C2 (de) * | 1993-09-20 | 1997-05-28 | Jenapharm Gmbh | 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US5391557A (en) * | 1993-10-15 | 1995-02-21 | Eli Lilly And Company | Methods for the treatment of peri-menopausal syndrome |
| CA2203541A1 (en) * | 1994-10-24 | 1996-05-02 | Kristof Chwalisz | Competitive progesterone antagonists for demand-oriented female birth control |
| DE19610635A1 (de) * | 1996-03-11 | 1997-09-18 | Schering Ag | Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie |
| WO1997049407A1 (en) * | 1996-06-25 | 1997-12-31 | Akzo Nobel N.V. | Progestogen-anti-progestogen regimens |
| WO1998005679A2 (en) * | 1996-08-05 | 1998-02-12 | Duke University | Mixed agonists of the progesterone receptor and assays therefor |
| DE19809845A1 (de) * | 1998-03-03 | 1999-09-09 | Jenapharm Gmbh | S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
| TR200102041T2 (tr) * | 1999-01-14 | 2001-12-21 | Bayer Corporation | Progesteron reseptör bağlama aktif maddeleri olarak ikameli 2-arilimino heterosaykıllar |
-
2000
- 2000-08-31 CO CO00065516A patent/CO5200773A1/es not_active Application Discontinuation
- 2000-08-31 CN CN00812257A patent/CN1454088A/zh active Pending
- 2000-08-31 IL IL14841700A patent/IL148417A0/xx unknown
- 2000-08-31 KR KR1020027002815A patent/KR100729311B1/ko not_active IP Right Cessation
- 2000-08-31 NZ NZ517469A patent/NZ517469A/en unknown
- 2000-08-31 SI SI200020041A patent/SI20851B/sl not_active IP Right Cessation
- 2000-08-31 RS YUP-141/02A patent/RS50396B/sr unknown
- 2000-08-31 AU AU36332/01A patent/AU781836B2/en not_active Ceased
- 2000-08-31 DE DE60040764T patent/DE60040764D1/de not_active Expired - Lifetime
- 2000-08-31 JP JP2001536126A patent/JP2003513908A/ja active Pending
- 2000-08-31 HU HU0202460A patent/HUP0202460A3/hu unknown
- 2000-08-31 RO ROA200200230A patent/RO122180B1/ro unknown
- 2000-08-31 EA EA200200285A patent/EA007840B1/ru not_active IP Right Cessation
- 2000-08-31 PL PL353931A patent/PL198798B1/pl not_active IP Right Cessation
- 2000-08-31 EE EEP200200102A patent/EE200200102A/xx unknown
- 2000-08-31 WO PCT/US2000/023771 patent/WO2001034126A2/en active IP Right Grant
- 2000-08-31 PE PE2000000892A patent/PE20010581A1/es not_active Application Discontinuation
- 2000-08-31 AR ARP000104537A patent/AR025456A1/es unknown
- 2000-08-31 UA UA2002032428A patent/UA75339C2/uk unknown
- 2000-08-31 AT AT00991840T patent/ATE413168T1/de not_active IP Right Cessation
- 2000-08-31 ES ES00991840T patent/ES2316402T3/es not_active Expired - Lifetime
- 2000-08-31 EP EP00991840A patent/EP1605924B1/en not_active Expired - Lifetime
- 2000-08-31 SK SK297-2002A patent/SK287121B6/sk not_active IP Right Cessation
- 2000-08-31 CA CA002383659A patent/CA2383659C/en not_active Expired - Lifetime
- 2000-08-31 BR BR0013710-3A patent/BR0013710A/pt not_active Application Discontinuation
- 2000-08-31 CZ CZ20020706A patent/CZ301412B6/cs not_active IP Right Cessation
-
2002
- 2002-02-26 BG BG106443A patent/BG65846B1/bg unknown
- 2002-02-26 ZA ZA200201621A patent/ZA200201621B/en unknown
- 2002-02-27 IL IL148417A patent/IL148417A/en not_active IP Right Cessation
- 2002-02-28 NO NO20021000A patent/NO20021000L/no not_active Application Discontinuation
- 2002-02-28 MX MXPA02002190A patent/MXPA02002190A/es active IP Right Grant
- 2002-03-27 LT LT2002037A patent/LT5011B/lt not_active IP Right Cessation
- 2002-03-28 HR HR20020266A patent/HRP20020266A2/hr not_active Application Discontinuation
- 2002-03-28 LV LVP-02-54A patent/LV12942B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP077236A (es) | Moduladores del receptor de progesterona que comprenden los derivados del pirrol-oxindol y los usos de los mismos | |
| PA8638801A1 (es) | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
| EA200400337A1 (ru) | Применение модулятора рецепторов глюкокортикоидов и агониста рецепторов глюкокортикоидов при получении лекарственного средства | |
| AR048185A1 (es) | Sistema de entrega de farmacos constituido por uno o mas compartimentos, que comprende un compuesto progestagenico disuelto en un copolimero de polietileno acetato de vinilo termoplastico | |
| TR200200507T2 (tr) | Androjen reseptörü modülatör bileşikleri ve metotları | |
| ME00292B (me) | Drospirenon za terapiju zamjene hormona | |
| NI201000184A (es) | Composiciones y métodos para tratar el cáncer del seno. | |
| UY27595A1 (es) | Compuestos de succinimida heterocíclicos, fusionados y analógos de los mismos, moduladores de la función del receptor de la hormona nuclear | |
| UY26808A1 (es) | Compuestos de succinimida heterocíclicos fusionados y análogos de los mismos, modulares de la función del receptor de hormona nuclear | |
| UY28231A1 (es) | Metodos y composiciones farmacéuticas para la obtención confiable de niveles aceptables de testosterona en suero. | |
| BRPI0519031A2 (pt) | compostos e composiÇÕes como moduladores de atividades de receptores esteroidais e de canal de cÁlcio | |
| DOP2012000325A (es) | Derivados de 6,7-dihidro-5h-benzo (7)anulenos, metodos para su preparacion, preparaciones farmaceuticas que los contienen y su uso para la preparacion de medicamentos | |
| CR7611A (es) | Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona | |
| UA37259C2 (uk) | Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч | |
| ECSP077323A (es) | Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias | |
| AR022251A1 (es) | Antagonistas de factor de necrosis tumoral y uso de los mismos en endometrosis. | |
| PE20040068A1 (es) | Decanoato, undecanoato y dodecanoato de etonogestrel | |
| AR025456A1 (es) | Mesoprogestinas (moduladores de receptor de progesterona) como componentes de composiciones utilizadas para la terapia de sustitucion hormonal (trh) | |
| ATE382356T1 (de) | Pharmazeutische zusammensetzung enthaltend estetrolderivate und anwendung in der krebsbehandlung | |
| ECSP088147A (es) | Moduladores del receptor de la cianopirrol-sulfonamida progesterona y los usos de los mismos | |
| UY32005A (es) | Derivados de estratrieno que comprenden bioisósteros heterocíclicos para el anillo fenólico a | |
| AR025457A1 (es) | Mesoprogestinas (moduladores de receptores de progesterona) para el tratamiento y la prevencion de trastornos ginecologicos benignos hormona-dependientes | |
| ATE419855T1 (de) | Therapie für hormonersatz und depression enthaltend dienogest | |
| UY26809A1 (es) | Moduladores cíclicos fusionados de función de receptor hormonal nuclear | |
| CL2007002788A1 (es) | Un compuesto derivado de (cis)-8-fluorodibenzo[b,f]pirido[1,2-d]oxazepin-1-amina, modulador de los receptores de progesterona; composicion farmaceutica; y uso como anticonceptivo, para la terapia de reemplazo hormonal o para el tratamiento de un tras |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |